Silver sulphadiazine: A comprehensive in vitro reassessment

Chemotherapy

Volumn 39, Issue 6, 1993, Pages 405-409

  Hamilton Miller, J M T ^a   Shah, Saroj ^a   Smith, Craig ^a  

^a ROYAL FREE HOSPITAL   (United Kingdom)

Author keywords

Acinetobacter spp; Methicillin resistance; Silver sulphadiazine; Staphylococcus aureus; Sulphonamides

Indexed keywords

METICILLIN; SULFADIAZINE SILVER; SULFONAMIDE;

ACINETOBACTER; ANTIBACTERIAL ACTIVITY; ANTIMICROBIAL ACTIVITY; ARTICLE; DRUG SENSITIVITY; LETHALITY; MINIMUM INHIBITORY CONCENTRATION; MULTIDRUG RESISTANCE; NONHUMAN; PENICILLIN RESISTANCE; PRIORITY JOURNAL; STAPHYLOCOCCUS AUREUS;

ACINETOBACTER; COMPARATIVE STUDY; DRUG RESISTANCE, MICROBIAL; METHICILLIN RESISTANCE; MICROBIAL SENSITIVITY TESTS; SILVER SULFADIAZINE; SPECIES SPECIFICITY; STAPHYLOCOCCUS AUREUS; STAPHYLOCOCCUS EPIDERMIDIS; SUPPORT, NON-U.S. GOV'T;

EID: 0027360863     PISSN: 00093157     EISSN: 14219794     Source Type: Journal    
DOI: 10.1159/000238985     Document Type: Article

References (21)

1. Fox CL: Silver sulphadiazine - A new topical therapy for Pseudomonas burns. Arch Surg 1968;96:184- 188.
2. Maple PAC, Hamilton-Miller JMT, Brumfitt W: World-wide antibiotic resistance in methicillin-resistant Staphylococcus aureus. Lancet 1989; i:537-540.
3. Novick RP: Analysis by transduction of mutations affecting penicillinase formation in Staphylococcus aureus. J Gen Microbiol 1963;33:121-136.
4. Reynolds JEF (ed): Martindale: The Extra Pharmacopoeia, ed 29. London, Pharmaceutical Press, 1989.
5. Nesbitt RU, Sandmann BJ: Solubility studies of silver sulfadiazine. J Pharm Sci 1977;66:519-522.
6. Carr HS, Wlodkowski TJ, Rosenkranz HS: Silver sulfadiazine: In vitro antibacterial activity. Antimicrob Agents Chemother 1973;4:585-587.
7. Wlodkowski TJ, Rosenkranz HS: Antifungal activity of silver sulphadiazine. Lancet l973;ii:739-740.
8. Fox CL, Modak SM: Mechanism of silver sulfadiazine action on burn wound infections. Antimicrob Agents Chemother 1974;6:582-588.
9. Rosenkranz HS, Coward JE, Wlodkowski TJ, Carr HS: Properties of silver sulfadiazine-resistant Enterobacter cloacae. Antimicrob Agents Chemother 1974;5:199-201.
10. Speck WT, Rosenkranz HS: Activity of silver sulphadiazine against dermatophytes. Lancet 1974;ii:895-896.
11. Fox CL, Monafo WW, Ayvazian VH, Skinner AM, Modak S, Standford J, Condict C: Topical chemotherapy for burns using cerium salts and silver sulfadiazine. Surg Gynecol Obstet 1977;144:668-672.
12. Saffer LD, Rodeheaver GT, Hiebert JM, Edlich RF: In vivo and in vitro activity of silver sulfadiazine and cerium nitrate. Surg Gynecol Obstet 1980;151:232-236.
13. Modak SM, Fox CL: Sulfadiazine silver-resistant Pseudomonas in burns. Arch Surg 1981;116:854-857.
14. McManus AT, Denton CL, Vlason AD: Mechanisms of in vitro sensitivity to sulfadiazine silver. Arch Surg 1983;118:161-166.
15. Richards RME, Xing DKL: Evaluation of synergistic effects of combinations of antibacterials having relevance to treatment of burn wound infections. Int J Pharm 1991;75: 81-88.
16. Richards RME, Taylor RB, Xing DKL: An evaluation of the antibacterial activities of combinations of sulfonamides, trimethoprim, dibromopropamidine, and silver nitrate compared with their uptakes by selected bacteria. J Pharm Sci 1991; 80:861-867.
17. de Wit PP, van Doorne H, Bull A: Synthesis, physical properties and microbiological activities of more water soluble silver sulfadiazine derivates. Pharm Weekbl Sci 1983;5: 298-301.
18. Reynolds AV, Hamilton-Miller JMT, Brumfitt W: Discrepant behaviour of clotrimazole against Bacteroides fragills in liquid and solid media. J Antimicrob Chemother 1977;3:622-623.
19. Bult A: Silver sulfadiazine and related antibacterial metal sulfanilamides: Facts and fancy. Pharm Int 1982;3:400-404.
20. Joly-Guillou ML, Bergogne-Berezon E, Moreau N: Enzymatic resistance to β-lactams and aminoglycosides in Acinetobacter calcoaceticus. J Antimicrob Chemother 1987;20: 773-776.
21. Brumfitt W, Hamilton-Miller JMT: Methicillin-resistant Staphylococcus aureus. New Engl J Med 1989;320: 1188-1196.